in the context of the full reply though she mentions that so many companies in the current environment want to do combo therapies but cant due to toxicity issues , she even mentions that it could be used in combination with existing treatments like Keytruda etc , so I took the dance card comment to mean that they wouldnt be looking to an exclusive partner for something like this and more likely to licence out to those who are interested ... my opinion only but thats how i interpreted it ...
either way , it looks positive at this early stage.
Ann: Imugene Dose Escalates in PD1-VAXX Phase 1 Clinical Trial, page-61
-
- There are more pages in this discussion • 242 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
-0.002(3.51%) |
Mkt cap ! $402.5M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 5.7¢ | 5.4¢ | $1.042M | 18.87M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 628179 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 897037 | 6 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |